Fennec Pharmaceuticals Inc (FENC)

R&D to Revenue

0.66%

Quarterly · Period ending:

FENC logo

FENC R&D to Revenue

Latest reported0.66%
FENC Quarterly R&D/Revenue (0.00% → 0.66%)
High-resolution chart · PNG

FENC r&d to revenue history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Fennec Pharmaceuticals Inc R&D to Revenue — Quarterly
Period endingR&D to Revenue
0%
0%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.